Extract from the above information

Not described in detail

It regulates calcium metabolism and inhibits one of the hormones of the parathyroid gland. It can significantly reduce the bone calcium loss of high-turnover bone diseases, inhibit osteoclast activity, stimulate osteoblast formation and activity, inhibit osteolysis, reduce pathologically elevated blood calcium concentration, increase urinary calcium, phosphorus and blood sodium excretion, inhibit the secretion activity of the stomach and pancreas, and has an analgesic effect on patients with certain painful bone diseases.

This product is a calcium metabolism regulator. Calcitonin is a polypeptide hormone secreted by thyroid cells. It has the function of inhibiting the activity of osteoclasts, thereby inhibiting the dissolution of bone salts and preventing the release of calcium from bones. Since the bone's uptake of calcium is still ongoing, it can lower blood calcium.

Recombinant streptokinase combines with plasminogen in a 1:1 molar ratio to form a complex, which then activates plasminogen into plasmin. Plasmin catalyzes the hydrolysis of fibrin, the main matrix of thrombus, thereby dissolving the thrombus and reopening the blood vessels. At the same time, the thrombolytic effect of recombinant streptokinase is enhanced by the presence of fibrin. Therefore, recombinant streptokinase can effectively and specifically dissolve thrombus or blood clots, and can treat diseases with thrombosis as the main pathological change.